Based on above issues, we carried out this study to analyze the accuracy of CNB in determining biomarker status, define factors influencing Ki67 alteration after CNB, and evaluate the potential prognostic value of Ki67 alteration between OEB and CNB in early breast cancer patients. The gene discussed is MKI67; the disease is breast carcinoma.